{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:43:24Z","timestamp":1791924204784,"version":"4.3.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-43754-8","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T05:15:22Z","timestamp":1773033322000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Trends in renal failure\u2013related mortality among U.S. multiple myeloma patients aged\u2009\u2265\u200945 years, 1999\u20132023: analysis of CDC data"],"prefix":"10.1038","volume":"16","author":[{"given":"Ye","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghua","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongping","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"issue":"4","key":"43754_CR1","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1093\/ndt\/gfp679","volume":"25","author":"DJ Tsakiris","year":"2010","unstructured":"Tsakiris, D. J. et al. Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: An ERA-EDTA Registry study. Nephrol. Dial. Transplant. 25(4), 1200\u20131206 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"issue":"13","key":"43754_CR2","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1200\/JCO.2015.65.0044","volume":"34","author":"MA Dimopoulos","year":"2016","unstructured":"Dimopoulos, M. A. et al. International myeloma working group recommendations for the diagnosis and management of myeloma-related renal impairment. J. Clin. Oncol. 34(13), 1544\u20131557 (2016).","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"43754_CR3","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1038\/leu.2008.131","volume":"22","author":"MA Dimopoulos","year":"2008","unstructured":"Dimopoulos, M. A. et al. Pathogenesis and treatment of renal failure in multiple myeloma. Leukemia 22(8), 1485\u20131493 (2008).","journal-title":"Leukemia"},{"issue":"5","key":"43754_CR4","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/bmt.2011.168","volume":"47","author":"MM J\u00f6ris","year":"2012","unstructured":"J\u00f6ris, M. M. et al. Access to allogeneic hematopoietic SCT for patients with MDS or relapsed AML treated according to protocols of the Dutch Childhood Oncology Group. Bone Marrow Transplant. 47(5), 677\u2013683 (2012).","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"43754_CR5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1182\/blood-2010-03-273656","volume":"117","author":"K Sch\u00f6nberg","year":"2011","unstructured":"Sch\u00f6nberg, K. et al. Analyses of HLA-C\u2013specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition. Blood 117(1), 98\u2013107 (2011).","journal-title":"Blood"},{"issue":"4","key":"43754_CR6","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1182\/bloodadvances.2016002493","volume":"1","author":"LJ Costa","year":"2017","unstructured":"Costa, L. J. et al. Recent trends in multiple myeloma incidence and survival by age, race, and ethnicity in the United States. Blood Adv. 1(4), 282\u2013287 (2017).","journal-title":"Blood Adv."},{"issue":"7","key":"43754_CR7","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","volume":"20","author":"A Francis","year":"2024","unstructured":"Francis, A. et al. Chronic kidney disease and the global public health agenda: An international consensus. Nat. Rev. Nephrol. 20(7), 473\u2013485 (2024).","journal-title":"Nat. Rev. Nephrol."},{"issue":"10159","key":"43754_CR8","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","volume":"392","author":"KJ Foreman","year":"2018","unstructured":"Foreman, K. J. et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: Reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet 392(10159), 2052\u20132090 (2018).","journal-title":"Lancet"},{"issue":"10053","key":"43754_CR9","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","volume":"388","author":"H Wang","year":"2016","unstructured":"Wang, H. et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet 388(10053), 1459\u20131544 (2016).","journal-title":"Lancet"},{"issue":"52","key":"43754_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013638","volume":"97","author":"I Boudhabhay","year":"2018","unstructured":"Boudhabhay, I. et al. Multiple myeloma with crystal-storing histiocytosis, crystalline podocytopathy, and light chain proximal tubulopathy, revealed by retinal abnormalities: A case report. Medicine 97(52), e13638 (2018).","journal-title":"Medicine"},{"issue":"1","key":"43754_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s00108-018-0538-7","volume":"60","author":"V G\u00f6decke","year":"2019","unstructured":"G\u00f6decke, V. et al. Diagnosis and treatment of kidney involvement in plasma cell diseases: Renal involvement in multiple myeloma and monoclonal gammopathies. Internist (Berl) 60(1), 10\u201322 (2019).","journal-title":"Internist (Berl)"},{"issue":"9","key":"43754_CR12","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1681\/ASN.2006020139","volume":"17","author":"SM Korbet","year":"2006","unstructured":"Korbet, S. M. & Schwartz, M. M. Multiple myeloma. J. Am. Soc. Nephrol. 17(9), 2533\u20132545 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"43754_CR13","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/sj.ki.5002416","volume":"73","author":"SH Nasr","year":"2008","unstructured":"Nasr, S. H. et al. Myeloma cast nephropathy, direct renal infiltration by myeloma, and renal extramedullary hematopoiesis. Kidney Int. 73(4), 517\u2013518 (2008).","journal-title":"Kidney Int."},{"issue":"12","key":"43754_CR14","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.2215\/CJN.11161111","volume":"7","author":"N Leung","year":"2012","unstructured":"Leung, N. et al. Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseases. Clin. J. Am. Soc. Nephrol. 7(12), 1964\u20131968 (2012).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"17","key":"43754_CR15","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/j.jacc.2023.02.044","volume":"81","author":"MH Maqsood","year":"2023","unstructured":"Maqsood, M. H. et al. CDC-WONDER database analysis of COVID-19 and cardiovascular disease-related mortality. J. Am. Coll. Cardiol. 81(17), 1743\u20131745 (2023).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"43754_CR16","doi-asserted-by":"publisher","first-page":"e809","DOI":"10.1016\/j.clml.2025.06.002","volume":"25","author":"M Rehmat","year":"2025","unstructured":"Rehmat, M. et al. Renal failure-related mortality in multiple myeloma: United States trends from 1999 to 2020. Clin. Lymphoma Myeloma Leuk. 25(10), e809-e817.e10 (2025).","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"3","key":"43754_CR17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.71079\/ASIDE.IM.092725233","volume":"2","author":"AA Ibrahim","year":"2025","unstructured":"Ibrahim, A. A. et al. Disparities and trends in polycythemia vera\u2013related mortality in U.S. adults aged \u226545 years from 1999 to 2023. ASIDE Internal Med. 2(3), 24\u201332 (2025).","journal-title":"ASIDE Internal Med."},{"key":"43754_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1567305","volume":"15","author":"G Folino","year":"2025","unstructured":"Folino, G. et al. Temporal trends of cervical cancer demographics: A CDC WONDER database study. Front. Oncol. 15, 1567305 (2025).","journal-title":"Front. Oncol."},{"issue":"10","key":"43754_CR19","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/cac2.12197","volume":"41","author":"H Qiu","year":"2021","unstructured":"Qiu, H., Cao, S. & Xu, R. Cancer incidence, mortality, and burden in China: A time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020. Cancer Commun. (Lond.) 41(10), 1037\u20131048 (2021).","journal-title":"Cancer Commun. (Lond.)"},{"issue":"21","key":"43754_CR20","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1001\/jama.2017.17924","volume":"318","author":"F Bridoux","year":"2017","unstructured":"Bridoux, F. et al. Effect of high-cutoff hemodialysis vs conventional hemodialysis on hemodialysis independence among patients with myeloma cast nephropathy: A randomized clinical trial. JAMA 318(21), 2099\u20132110 (2017).","journal-title":"JAMA"},{"issue":"3","key":"43754_CR21","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/S1470-2045(18)30072-X","volume":"19","author":"N Raje","year":"2018","unstructured":"Raje, N. et al. Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: An international, double-blind, double-dummy, randomised, controlled, phase 3 study. Lancet Oncol. 19(3), 370\u2013381 (2018).","journal-title":"Lancet Oncol."},{"issue":"9","key":"43754_CR22","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/clinchem\/48.9.1437","volume":"48","author":"JA Katzmann","year":"2002","unstructured":"Katzmann, J. A. et al. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: Relative sensitivity for detection of monoclonal light chains. Clin. Chem. 48(9), 1437\u20131444 (2002).","journal-title":"Clin. Chem."},{"issue":"16","key":"43754_CR23","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1182\/blood-2012-03-413682","volume":"120","author":"N Leung","year":"2012","unstructured":"Leung, N., Nasr, S. H. & Sethi, S. How I treat amyloidosis: The importance of accurate diagnosis and amyloid typing. Blood 120(16), 3206\u20133213 (2012).","journal-title":"Blood"},{"issue":"2","key":"43754_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41408-022-00633-5","volume":"12","author":"J Dong","year":"2022","unstructured":"Dong, J. et al. Black patients with multiple myeloma have better survival than white patients when treated equally: A matched cohort study. Blood. Cancer. J. 12(2), 34 (2022).","journal-title":"Blood. Cancer. J."},{"issue":"10","key":"43754_CR25","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.clml.2020.05.013","volume":"20","author":"S Intzes","year":"2020","unstructured":"Intzes, S. et al. Socioeconomic status is an independent prognostic factor for overall survival in patients with multiple myeloma: Real-world data from a cohort of 223 patients. Clin. Lymphoma Myeloma Leuk. 20(10), 704\u2013711 (2020).","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"1","key":"43754_CR26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jaci.2022.11.001","volume":"151","author":"A Long","year":"2023","unstructured":"Long, A., Kleiner, A. & Looney, R. J. Immune dysregulation. J. Allergy Clin. Immunol. 151(1), 70\u201380 (2023).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"43754_CR27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1182\/blood.2023023156","volume":"145","author":"N G\u00f6kbuget","year":"2025","unstructured":"G\u00f6kbuget, N. & Steffen, B. How I treat older patients with Ph\/BCR-ABL-negative acute lymphoblastic leukemia. Blood 145(1), 53\u201363 (2025).","journal-title":"Blood"},{"issue":"6","key":"43754_CR28","first-page":"587","volume":"36","author":"L Gallicchio","year":"2025","unstructured":"Gallicchio, L. et al. Rare cancer survivorship research funding at the National Institutes of Health (NIH), 2017 to 2023. Cancer Causes Control 36(6), 587\u2013594 (2025).","journal-title":"Cancer Causes Control"},{"issue":"1","key":"43754_CR29","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1182\/bloodadvances.2023011457","volume":"8","author":"KA Bertrand","year":"2024","unstructured":"Bertrand, K. A. & Szalat, R. Deciphering racial disparities in multiple myeloma outcomes. Blood. Adv. 8(1), 234\u2013235 (2024).","journal-title":"Blood. Adv."},{"issue":"10077","key":"43754_CR30","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(17)30569-X","volume":"389","author":"ZD Bailey","year":"2017","unstructured":"Bailey, Z. D. et al. Structural racism and health inequities in the USA: Evidence and interventions. Lancet 389(10077), 1453\u20131463 (2017).","journal-title":"Lancet"},{"issue":"1","key":"43754_CR31","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41375-020-0812-2","volume":"35","author":"F Covut","year":"2021","unstructured":"Covut, F. et al. Racial and age-related disparities in early mortality affect the outcomes of multiple myeloma patients. Leukemia 35(1), 250\u2013254 (2021).","journal-title":"Leukemia"},{"issue":"10","key":"43754_CR32","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.clml.2020.04.018","volume":"20","author":"MA Fiala","year":"2020","unstructured":"Fiala, M. A., Wildes, T. M. & Vij, R. Racial disparities in the utilization of novel agents for frontline treatment of multiple myeloma. Clin. Lymphoma Myeloma Leuk. 20(10), 647\u2013651 (2020).","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"3","key":"43754_CR33","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1080\/10428190902741471","volume":"50","author":"CR Friese","year":"2009","unstructured":"Friese, C. R. et al. Diagnostic delay and complications for older adults with multiple myeloma. Leuk. Lymphoma 50(3), 392\u2013400 (2009).","journal-title":"Leuk. Lymphoma"},{"issue":"1","key":"43754_CR34","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.121.007917","volume":"15","author":"Z Javed","year":"2022","unstructured":"Javed, Z. et al. Race, racism, and cardiovascular health: Applying a social determinants of health framework to racial\/ethnic disparities in cardiovascular disease. Circ. Cardiovasc. Qual. Outcomes 15(1), e007917 (2022).","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"issue":"10","key":"43754_CR35","doi-asserted-by":"publisher","first-page":"4776","DOI":"10.1111\/dom.15797","volume":"26","author":"S Neupane","year":"2024","unstructured":"Neupane, S. et al. Regional disparities in type 2 diabetes prevalence and associated risk factors in the United States. Diabetes Obes. Metab. 26(10), 4776\u20134782 (2024).","journal-title":"Diabetes Obes. Metab."},{"issue":"7","key":"43754_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2022.108208","volume":"36","author":"J Uddin","year":"2022","unstructured":"Uddin, J. et al. Trends in diagnosed hypertension prevalence by geographic region for older adults with and without diagnosed diabetes, 2005\u20132017. J. Diabetes Complic. 36(7), 108208 (2022).","journal-title":"J. Diabetes Complic."},{"issue":"1","key":"43754_CR37","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s12882-024-03717-5","volume":"25","author":"BN Cesar","year":"2024","unstructured":"Cesar, B. N. et al. Kidney function in newly diagnosed myeloma patients: Factors associated with kidney impairment and recovery. BMC Nephrol. 25(1), 344 (2024).","journal-title":"BMC Nephrol."},{"issue":"5","key":"43754_CR38","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/(SICI)1097-0274(199711)32:5<510::AID-AJIM11>3.0.CO;2-5","volume":"32","author":"SA Khuder","year":"1997","unstructured":"Khuder, S. A. & Mutgi, A. B. Meta-analyses of multiple myeloma and farming. Am. J. Ind. Med. 32(5), 510\u2013516 (1997).","journal-title":"Am. J. Ind. Med."},{"issue":"6","key":"43754_CR39","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.puhe.2015.04.001","volume":"129","author":"N Douthit","year":"2015","unstructured":"Douthit, N. et al. Exposing some important barriers to health care access in the rural USA. Public Health 129(6), 611\u2013620 (2015).","journal-title":"Public Health"},{"issue":"5","key":"43754_CR40","doi-asserted-by":"publisher","first-page":"550","DOI":"10.5993\/AJHB.33.5.8","volume":"33","author":"WE Zahnd","year":"2009","unstructured":"Zahnd, W. E., Scaife, S. L. & Francis, M. L. Health literacy skills in rural and urban populations. Am. J. Health Behav. 33(5), 550\u2013557 (2009).","journal-title":"Am. J. Health Behav."},{"key":"43754_CR41","doi-asserted-by":"publisher","DOI":"10.71079\/aside.im.120125291","author":"AA Ibrahim","year":"2025","unstructured":"Ibrahim, A. A. et al. Multiple myeloma and chronic kidney disease\u2013related mortality, 1999\u20132023: A population-based time-trend analysis. ASIDE Internal Med. https:\/\/doi.org\/10.71079\/aside.im.120125291 (2025).","journal-title":"ASIDE Internal Med."},{"key":"43754_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1735565","volume":"15","author":"Y Jiang","year":"2025","unstructured":"Jiang, Y., Liang, G. & Cao, Y. Trends in mortality rates associated with multiple myeloma in the United States, 1999-2023. Front. Oncol. 15, 1735565 (2025).","journal-title":"Front. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43754-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43754-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43754-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T01:03:00Z","timestamp":1776387780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43754-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["43754"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-43754-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"12 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12661"}}